Global Avascular Necrosis Market – Overview
The Avascular Necrosis Market is projected to increase at a CAGR of 6.58 percent during the forecast period (2018-2024) and is projected to reach valuation of USD 1.12 Billion by 2024.
The avascular necrosis industry globally is motivated by the growing occurrence of bone diseases such as osteoarthritis and osteoporosis together with the mounting cases of alcohol abuse and steroids, and implementation of the medication over surgery by the patients. However, strict regulatory requirements and lack of awareness in a majority of the population may curb the progress of the market in the forecast period.
Meanwhile, healthcare providers remain focused on providing low cost treatment to penetrate regional markets that have higher representation of price-sensitive patients. China and India currently account for nearly 40% of the total global population affected by AVN. These two countries present lucrative market opportunities, however, unstructured regulatory frameworks and lack of awareness are some of major blockades faced by healthcare providers in creating a wider access to medical care in these two countries.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/6131 .
This MRFR report delivers a detailed perspective on the global market for avascular necrosis. In-depth information on the market pertaining to historical market trends and current market scenario along with market forecast for the next six years is offered in the report. Key macro and micro-economic factors affecting the global avascular necrosis market were also discussed.
The report includes analysis of types of avascular necrosis, disease site, diagnosis, treatment, and end-user. Based on types, into trauma-related avascular necrosis (AVN) and non-trauma related avascular necrosis (AVN) were considered for market sizing. Hip bone, knee, and shoulder were the prominent disease sites discussed in the report for market valuation. The market share captured by imaging diagnosis and biopsy diagnosis was also examined. Based on treatment, medication, electrical stimulation, gene therapy, and surgery made up for the overall market size. Based on end user, the key market segments covered in the report include hospitals & clinics, diagnostic centers, and ambulatory surgical centers. All the segments and sub-segments are profiled under five major regions–North America, Latin America, Europe, Asia Pacific (APAC) and the Middle East & Africa (MEA), with the respective country-level market sizes. The report analyses the current and future prospect of the market and delivers an unbiased growth assessment.
Avascular Necrosis Market Players Covered
Stryker Corporation, Medtronic plc, Ethicon Inc., Sanofi SA, Bayer AG, Pfizer Inc., Merck KGaA, Boehringer Ingelheim GmbH, Eli Lilly and Company, Aurobindo Pharma, Integra LifeSciences Corporation, Zimmer Biomet Holdings, Wright Medical Group N.V., Grifols SA, and Smith and Nephew.
Global Avascular Necrosis Market – Regional Analysis
The region wise segmentation of the market comprises of regions such as Europe, Americas, the Middle East & Africa (MEA) and Asia Pacific (APAC). The Americas region is presently attributed for the chief market share, and the trend is expected to carry on in the foreseeable future. This is attributable to the robust value upheld by the hip bone replacement segment in both the U.S. and other Latin American nations. Furthermore, the medical device industry is one of the principal ventures in the US. The Asia Pacific and European regions are also anticipated to continue its significant growth in various revenue pockets for the avascular necrosis (AVN) market during the forecast period. While the APAC region’s trajectory is mostly directed by factors such as improved equipment and infrastructure and intensifying R&D initiatives to increase the effectiveness and efficacy of new drugs. The increasing demand for reduced cost of treatment procedures in emerging countries such as China and India has improved the demand development of minimally invasive surgeries. These two nations are responsible for almost 40% of the total global population affected with AVN disease. Strict regulatory requirements and absence of awareness in the majority of the population may confine the expansion of the market in the asessment period.
Major TOC For Avascular Necrosis Market Research Report – Forecast to 2024
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
2.4 Market Structure
3 RESEARCH METHODOLOGY
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 MARKET DYNAMICS
4.2.1 Increasing Awareness Along With The High Prevalence Of The Avascular Necrosis Disease
4.2.2 Rising Preference Of Surgeries To Cure Osteonecrosis
4.2.3 Rising Preference Of Bone Grafting Surgical Procedures With The Less Pain Substitute Procedures
4.2.4 Consolidation Of Large Healthcare Providers In The U.S
4.2.5 Technological Advancements In The Development Of Surgical Implants
4.3.1 The High Cost Of Surgical Procedures And Related Side Effects
4.3.2 Worsening Regulatory Landscape And Growing Cost Of Noncompliance In Developed Countries
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/6131 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312